WebPhotocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. … WebAug 10, 2024 · Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q1 2024: NOK 88.9 million), and a positive EBITDA of NOK 1.4 million (NOK 5.8 ...
Did you know?
WebApr 12, 2024 · PR Newswire. OSLO, Norway, April 12, 2024 /PRNewswire/ -- Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2024. The Board of Directors of Photocure ... WebFeb 23, 2024 · OSLO, Norway , Feb. 23, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 94.9 million in the fourth quarter of 2024 (Q4 2024: NOK 94.2 million ), and an EBITDA of minus NOK 16.9 million ( NOK -5.5 million ). The total revenues increased 10% to NOK 104.2 million and there were 57 blue …
WebMar 21, 2024 · Oslo, Norway, March 21, 2024 – Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces Karl Storz’s continued commitment to blue light cystoscopy with plans to maximize the ongoing rollout of its new high-definition rigid blue light cystoscopy (BLC ®) system, Saphira™.Due to previously disclosed component supply …
WebApr 12, 2024 · Oslo, Norway, 12 April 2024: Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2024.. The Board of Directors of Photocure ASA has approved the annual accounts for 2024. The financial statements and annual report for the financial year 2024 are together with the ESG report and auditor's … WebAug 10, 2024 · Oslo, Norway, 10 August 2024: Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q2 2024: NOK 88.9 million), and a positive EBITDA of NOK 1.4 million (NOK 5.8 million). Karl Storz’s new high-definition blue light system is expected to become commercially available in the ...
WebMay 19, 2024 · Photocure reported total group revenues of NOK 88.2 million in the first quarter of 2024 ( NOK 55.0 million ), with an EBITDA* before restructuring of NOK 18.1 …
WebAug 10, 2024 · OSLO, Norway, Aug. 10, 2024 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q1 2024: NOK 88.9 million), and a ... flashcard boxesWebMar 14, 2024 · OSLO, Norway, March 14, 2024 /PRNewswire/ -- Photocure ASA(OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the European Association of Urology congress (EAU) in Milan, Italy, highlighting the benefits of Blue Light Cystoscopy (BLC ®) in Bladder Cancer … flashcard borderWebApr 12, 2024 · OSLO, Norway, April 12, 2024 /PRNewswire/ -- Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2024. The Board of Directors of Photocure ASA has ... flashcard businessWebFeb 23, 2024 · OSLO, Norway, Feb. 23, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 94.9 million in the fourth quarter of 2024 (Q4 2024: NOK 94.2 million), and ... flash card bordersWebApr 12, 2024 · PR Newswire. OSLO, Norway , April 12, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO), calls for the annual general meeting of Photocure ASA to be held on 3 May 2024 at 17:00 hours (CEST), virtual through the general meeting portal administered by Euronext Securities Oslo (the "Euronext Securities Portal"). The general meeting will be webcasted ... flashcard brown bearWebApr 12, 2024 · PR Newswire. OSLO, Norway , April 12, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO), calls for the annual general meeting of Photocure ASA to be held on 3 May … flashcard business card cutterWebApr 12, 2024 · Oslo, Norway, 12 April 2024: Photocure ASA (OSE: PHO), calls for the annual general meeting of Photocure ASA to be held on 3 May 2024 at 17:00 hours (CEST), … flash card cane